vs
Acadia Healthcare Company, Inc.（ACHC）与FULLER H B CO（FUL）财务数据对比。点击上方公司名可切换其他公司
FULLER H B CO的季度营收约是Acadia Healthcare Company, Inc.的1.1倍（$892.0M vs $821.5M），FULLER H B CO净利率更高（7.5% vs -143.3%，领先150.9%），Acadia Healthcare Company, Inc.同比增速更快（6.1% vs -2.8%），FULLER H B CO自由现金流更多（$68.9M vs $-179.5M），过去两年FULLER H B CO的营收复合增速更高（5.0% vs 3.4%）
阿卡迪亚医疗公司是美国的营利性行为医疗健康服务提供商，目前在美国及波多黎各地区运营着超过225家医疗机构，搭建了覆盖广泛的行为健康服务网络，为有相关需求的人群提供专业的心理健康与行为干预服务。
H.B.富勒公司是总部位于美国明尼苏达州圣保罗的跨国粘合剂制造企业，全球第四大粘合剂及密封剂生产商。公司拥有超过20000种产品，广泛应用于建筑、工程、电子、卫生用品、食品包装等领域，在26个国家设有81座生产基地，2024年员工规模约7500人。
ACHC vs FUL — 直观对比
营收规模更大
FUL
是对方的1.1倍
$821.5M
营收增速更快
ACHC
高出8.9%
-2.8%
净利率更高
FUL
高出150.9%
-143.3%
自由现金流更多
FUL
多$248.4M
$-179.5M
两年增速更快
FUL
近两年复合增速
3.4%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $821.5M | $892.0M |
| 净利润 | $-1.2B | $67.2M |
| 毛利率 | — | 32.0% |
| 营业利润率 | -142.4% | 12.3% |
| 净利率 | -143.3% | 7.5% |
| 营收同比 | 6.1% | -2.8% |
| 净利润同比 | -3710.4% | 21.3% |
| 每股收益（稀释后） | $-12.98 | $1.22 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ACHCFUL
| Q4 25 | $821.5M | — | ||
| Q3 25 | $851.6M | $892.0M | ||
| Q2 25 | $869.2M | $898.1M | ||
| Q1 25 | $770.5M | — | ||
| Q4 24 | $774.2M | — | ||
| Q3 24 | $815.6M | $917.9M | ||
| Q2 24 | $796.0M | — | ||
| Q1 24 | $768.1M | $810.4M |
净利润ACHCFUL
| Q4 25 | $-1.2B | — | ||
| Q3 25 | $36.2M | $67.2M | ||
| Q2 25 | $30.1M | $41.8M | ||
| Q1 25 | $8.4M | — | ||
| Q4 24 | $32.6M | — | ||
| Q3 24 | $68.1M | $55.4M | ||
| Q2 24 | $78.5M | — | ||
| Q1 24 | $76.4M | $31.0M |
毛利率ACHCFUL
| Q4 25 | — | — | ||
| Q3 25 | — | 32.0% | ||
| Q2 25 | — | 31.9% | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 30.0% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 29.5% |
营业利润率ACHCFUL
| Q4 25 | -142.4% | — | ||
| Q3 25 | 4.7% | 12.3% | ||
| Q2 25 | 5.8% | 11.1% | ||
| Q1 25 | 1.7% | — | ||
| Q4 24 | 4.9% | — | ||
| Q3 24 | 12.1% | 11.4% | ||
| Q2 24 | 13.4% | — | ||
| Q1 24 | 12.9% | 8.3% |
净利率ACHCFUL
| Q4 25 | -143.3% | — | ||
| Q3 25 | 4.3% | 7.5% | ||
| Q2 25 | 3.5% | 4.7% | ||
| Q1 25 | 1.1% | — | ||
| Q4 24 | 4.2% | — | ||
| Q3 24 | 8.4% | 6.0% | ||
| Q2 24 | 9.9% | — | ||
| Q1 24 | 9.9% | 3.8% |
每股收益（稀释后）ACHCFUL
| Q4 25 | $-12.98 | — | ||
| Q3 25 | $0.40 | $1.22 | ||
| Q2 25 | $0.33 | $0.76 | ||
| Q1 25 | $0.09 | — | ||
| Q4 24 | $0.36 | — | ||
| Q3 24 | $0.74 | $0.98 | ||
| Q2 24 | $0.85 | — | ||
| Q1 24 | $0.83 | $0.55 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $133.2M | $122.5M |
| 总债务越低越好 | $2.5B | — |
| 股东权益账面价值 | $1.9B | $2.0B |
| 总资产 | $5.5B | $5.2B |
| 负债/权益比越低杠杆越低 | 1.28× | — |
8季度趋势，按日历期对齐
现金及短期投资ACHCFUL
| Q4 25 | $133.2M | — | ||
| Q3 25 | $118.7M | $122.5M | ||
| Q2 25 | $131.4M | $96.8M | ||
| Q1 25 | $91.2M | — | ||
| Q4 24 | $76.3M | — | ||
| Q3 24 | $82.1M | $131.4M | ||
| Q2 24 | $77.2M | — | ||
| Q1 24 | $77.3M | $165.2M |
总债务ACHCFUL
| Q4 25 | $2.5B | — | ||
| Q3 25 | $2.3B | — | ||
| Q2 25 | $2.3B | — | ||
| Q1 25 | $2.2B | — | ||
| Q4 24 | $2.0B | — | ||
| Q3 24 | $1.9B | — | ||
| Q2 24 | $1.8B | — | ||
| Q1 24 | $1.9B | — |
股东权益ACHCFUL
| Q4 25 | $1.9B | — | ||
| Q3 25 | $3.1B | $2.0B | ||
| Q2 25 | $3.1B | $1.9B | ||
| Q1 25 | $3.0B | — | ||
| Q4 24 | $3.1B | — | ||
| Q3 24 | $3.0B | $1.8B | ||
| Q2 24 | $3.0B | — | ||
| Q1 24 | $2.9B | $1.8B |
总资产ACHCFUL
| Q4 25 | $5.5B | — | ||
| Q3 25 | $6.4B | $5.2B | ||
| Q2 25 | $6.3B | $5.1B | ||
| Q1 25 | $6.1B | — | ||
| Q4 24 | $6.0B | — | ||
| Q3 24 | $5.9B | $5.0B | ||
| Q2 24 | $5.7B | — | ||
| Q1 24 | $5.5B | $4.7B |
负债/权益比ACHCFUL
| Q4 25 | 1.28× | — | ||
| Q3 25 | 0.74× | — | ||
| Q2 25 | 0.74× | — | ||
| Q1 25 | 0.72× | — | ||
| Q4 24 | 0.64× | — | ||
| Q3 24 | 0.62× | — | ||
| Q2 24 | 0.62× | — | ||
| Q1 24 | 0.65× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-86.3M | $99.0M |
| 自由现金流经营现金流 - 资本支出 | $-179.5M | $68.9M |
| 自由现金流率自由现金流/营收 | -21.8% | 7.7% |
| 资本支出强度资本支出/营收 | 11.3% | 3.4% |
| 现金转化率经营现金流/净利润 | — | 1.47× |
| 过去12个月自由现金流最近4个季度 | $-439.9M | — |
8季度趋势，按日历期对齐
经营现金流ACHCFUL
| Q4 25 | $-86.3M | — | ||
| Q3 25 | $73.2M | $99.0M | ||
| Q2 25 | $133.5M | — | ||
| Q1 25 | $11.5M | — | ||
| Q4 24 | $116.7M | — | ||
| Q3 24 | $163.1M | $169.4M | ||
| Q2 24 | $171.1M | — | ||
| Q1 24 | $-321.3M | $47.4M |
自由现金流ACHCFUL
| Q4 25 | $-179.5M | — | ||
| Q3 25 | $-63.0M | $68.9M | ||
| Q2 25 | $-34.2M | — | ||
| Q1 25 | $-163.2M | — | ||
| Q4 24 | $-86.8M | — | ||
| Q3 24 | $-27.1M | $99.9M | ||
| Q2 24 | $16.9M | — | ||
| Q1 24 | $-463.7M | $4.1M |
自由现金流率ACHCFUL
| Q4 25 | -21.8% | — | ||
| Q3 25 | -7.4% | 7.7% | ||
| Q2 25 | -3.9% | — | ||
| Q1 25 | -21.2% | — | ||
| Q4 24 | -11.2% | — | ||
| Q3 24 | -3.3% | 10.9% | ||
| Q2 24 | 2.1% | — | ||
| Q1 24 | -60.4% | 0.5% |
资本支出强度ACHCFUL
| Q4 25 | 11.3% | — | ||
| Q3 25 | 16.0% | 3.4% | ||
| Q2 25 | 19.3% | — | ||
| Q1 25 | 22.7% | — | ||
| Q4 24 | 26.3% | — | ||
| Q3 24 | 23.3% | 7.6% | ||
| Q2 24 | 19.4% | — | ||
| Q1 24 | 18.5% | 5.3% |
现金转化率ACHCFUL
| Q4 25 | — | — | ||
| Q3 25 | 2.02× | 1.47× | ||
| Q2 25 | 4.43× | — | ||
| Q1 25 | 1.37× | — | ||
| Q4 24 | 3.58× | — | ||
| Q3 24 | 2.39× | 3.06× | ||
| Q2 24 | 2.18× | — | ||
| Q1 24 | -4.21× | 1.53× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ACHC
| Acute Inpatient Psychiatric Facilities | $451.2M | 55% |
| Comprehensive Treatment Centers | $144.2M | 18% |
| Medicare | $113.7M | 14% |
| Residential Treatment Centers | $89.7M | 11% |
| Self Payor | $16.1M | 2% |
| Other Payor | $10.7M | 1% |
FUL
| Hygiene Health And Consumable Adhesives | $386.1M | 43% |
| Engineering Adhesives | $272.3M | 31% |
| Building Adhesives Solutions | $233.7M | 26% |
